← Back to Clinical Trials
Recruiting NCT07177989

NCT07177989 Combined Effects of Alternate Nostril Breathing and Aerobic Interval Training on Blood Pressure and Heart Rate Products in Patients With Hypertension

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07177989
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Hypertension (HTN)
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2025-01-15
Primary Completion 2026-01-15

Trial Parameters

Condition Hypertension (HTN)
Sponsor Foundation University Islamabad
Study Type INTERVENTIONAL
Phase N/A
Enrollment 36
Sex ALL
Min Age 25 Years
Max Age 50 Years
Start Date 2025-01-15
Completion 2026-01-15
Interventions
Experimental Groupinterventional group A

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Hypertension (HTN) is the foremost preventable risk factor for cardiovascular disease (CVD) and all-cause mortality, contributing to over 7 million deaths annually within the nearly 17 million attributed to CVD. Effective management through lifestyle modifications, including aerobic exercises specifically interval training presents a promising avenue for blood pressure regulation by promoting vasodilation and regulating the autonomic nervous system. Likewise, alternate nostril breathing has demonstrated efficacy in lowering blood pressure by optimizing oxygenation and improving endothelial function but their combined effect on BP measures is yet to be determined. Hence this study aims to determine the combined effects of aerobic interval training with and without alternate nostril breathing on blood pressure, rate pressure product and quality of life in patients with hypertension.

Eligibility Criteria

Inclusion Criteria: * Adults aged 25- 50 years -males and females * Patients diagnosed with stage 1 hypertension 130 - 139 / 80 - 89 mmHg and stage 2 hypertension, BP level ≥140/90 mmHg. according to AHA/ACC 2017 Guidelines-Individuals who are able to understand and follow the instructions for exercise Exclusion Criteria: * Diagnosed with any current infections * subjects with diagnosed musculoskeletal or neurological conditions which hinder participation in physical activity program * Active Smokers * Those with any contraindication to exercise testing or training. * Pregnant females

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology